Work

Phase II Study of All-Trans Retinoic Acid (ATRA), Arsenic Trioxide (ATO), with or without Gemtuzumab OzogamIcin (GO) for the Frontline Therapy of Patients with Acute Promyelocytic Leukemia (APL).

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.1080.1080

Authors: Farhad Ravandi, Elihu H. Estey, Jorge E. Cortes, Susan O'Brien, Sherry A. Pierce, Mark Brandt, Alessandra Ferrajoli, Gautam Borthakur, Marina Konopleva, Srdan Verstovsek, Guillermo Garcia-Manero, Stefan Faderl, Hagop Kantarjian

Institutions: The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center

Language: English

Topic: Retinoids in leukemia and cellular processes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2530133575

FWCI: 1.17

Cites:

Cited by: 18

Related to: 10